Evidence map›Paper›PMID 37073790›Full record

ArticleJournal of rehabilitation medicine2023

Online monitoring of focal spasticity treatment with botulinum toxin in people with chronic stroke or hereditary spastic paraplegia: a feasibility study.

Hans C J W Kerstens, Maarten J Nijkrake, Bert J M De Swart, Ria W G Nijhuis-van der Sanden, Marije Vos-van de Hulst, Gery J Bos, Alexander C H Geurts, Philip J Van der Wees

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of rehabilitation medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hans C J W KerstensDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Neurorehabilitation, HAN University of Applied Sciences, Nijmegen, The Netherlands. hans.kerstens@han.nl.
Maarten J NijkrakeDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Bert J M De SwartDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Neurorehabilitation, HAN University of Applied Sciences, Nijmegen, The Netherlands.
Ria W G Nijhuis-van der SandenDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands.
Marije Vos-van de HulstDepartment of Rehabilitation, Rehabilitation center Sint Maartenskliniek, Nijmegen, The Netherlands.
Gery J BosDepartment of Rehabilitation, Rehabilitation center Tolbrug, Den Bosch, The Netherlands.
Alexander C H GeurtsDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Rehabilitation, Rehabilitation center Sint Maartenskliniek, Nijmegen, The Netherlands.
Philip J Van der WeesDepartment of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLHAN University of Applied Sciences · NLRadboud University Medical Center · NLSint Maartenskliniek · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the feasibility and usability of an online spasticity monitoring tool amongst people with hereditary spastic paraplegia or chronic stroke receiving botulinum toxin treatment, and their healthcare providers.

methodsMixed methods cohort study, measuring recruitment success and adherence to the monitoring in 3 rehabilitation institutions. In addition, the System Usability Scale (SUS) and interviews with patients and their healthcare providers were used for quantitative and qualitative analysis, respectively. A deductive directed content analysis was used for qualitative evaluation.

resultsOf the 19 persons with hereditary spastic paraplegia and 24 with stroke who enrolled in the study, recruitment success and adherence were higher amongst people with hereditary spastic paraplegia compared with stroke. Usability was found "marginal" by rehabilitation physicians and "good" by patients and physical therapists (SUS scores 69, 76, and 83, respectively). According to all participant groups, online monitoring potentially contributes to spasticity management if it is tailored to the actual needs and capabilities of patients, and if it can easily be integrated into the daily/working routines of all users.

conclusionOnline monitoring of spasticity in people with hereditary spastic paraplegia or stroke receiving treatment with botulinum toxin may be feasible, provided that the monitoring tool is tailored to the needs of all users.

Indexed as

Botulinum Toxins, Type ANeuromuscular AgentsSpastic Paraplegia, HereditaryStrokeCohort StudiesFeasibility StudiesHumansMuscle SpasticityBotulinum Toxins, Type ANeuromuscular Agents

Identifiers

PMID37073790
PMCPMC10170314
OpenAlexW4366352893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.